![Maria Ada Eufemia Forss](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Maria Ada Eufemia Forss
Direktor/Vorstandsmitglied bei
Mabtech AB
Vermögen: 141 980 $ am 31.08.2026
Profil
Maria Ada Eufemia Forss is currently Director at Mabtech AB. Former positions include Chief Executive Officer at DuoCort Pharma AB, President & Chief Executive Officer at BICO Group AB from 2023 to 2026, Chairman at Bico International AB, Deputy Director at Laccure AB, Director at Oncorena AB and Oncorena Holding AB, Independent Director at LIDDS AB, VP-Business Development & Global Communications at Vitrolife AB from 2012 to 2023, Head-Business Development at Aqilion AB, and Principal at AstraZeneca A. Education includes undergraduate and MBA degrees from Concordia University and graduate studies at Handelshögskolan i Göteborg.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BICO GROUP AB CLASS B 0,09 % | 29.04.2026 | 62 308 ( 0,09 % ) | 141 980 $ | 31.08.2026 |
Aktive Positionen von Maria Ada Eufemia Forss
| Unternehmen | Position | Beginn |
|---|---|---|
Mabtech AB
 Mabtech AB BiotechnologyHealth Technology Develops and sells tests & kits for studying immune responses though online | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Maria Ada Eufemia Forss
| Unternehmen | Position | Ende |
|---|---|---|
| BICO GROUP AB | Vorstandsvorsitzender | 31.08.2026 |
| VITROLIFE AB | Public Communications Contact | - |
Bico International AB | Vorsitzender | - |
Oncorena AB
 Oncorena AB Pharmaceuticals: MajorHealth Technology Develops a novel pharmacological treatment for metastasing clear cell renal cancer | Direktor/Vorstandsmitglied | - |
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is an active manager which invests companies located in Sweden. The firm follows of life science companies. It provides financing for early-stage capital requirements. | Corporate Officer/Principal | - |
Ausbildung von Maria Ada Eufemia Forss
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
52
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Vitrolife AB
 Vitrolife AB Medical SpecialtiesHealth Technology Develops, produces and markets products and systems for the preparation, cultivation and preservation of human cells, tissues and organs | Health Technology |
Concordia University
 Concordia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aqilion AB
Aqilion AB Investment ManagersFinance Aqilion AB is an active manager which invests companies located in Sweden. The firm follows of life science companies. It provides financing for early-stage capital requirements. | Finance |
Handelshögskolan i Göteborg
 Handelshögskolan i Göteborg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca A/S (Denmark)
 AstraZeneca A/S (Denmark) Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical medicines | Health Technology |
LIDDS AB
 LIDDS AB Pharmaceuticals: MajorHealth Technology Focuses on the development of treatment alternatives and hormonal therapy for prostate cancer | Health Technology |
Laccure AB
 Laccure AB Pharmaceuticals: GenericHealth Technology Develops products for treatment of bacterial vaginosis in the field of skin care and hygiene activities | Health Technology |
DuoCort Pharma AB
 DuoCort Pharma AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for glucocorticoid therapy | Health Technology |
Oncorena AB
Oncorena AB Pharmaceuticals: MajorHealth Technology Develops a novel pharmacological treatment for metastasing clear cell renal cancer | Health Technology |
Mabtech AB
Mabtech AB BiotechnologyHealth Technology Develops and sells tests & kits for studying immune responses though online | Health Technology |
Oncorena Holding AB
 Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Develops novel pharmacological treatment for metastasing clear cell renal cancer | Health Technology |
BICO Group AB
 BICO Group AB BiotechnologyHealth Technology Develops tools for bioprinting technology | Health Technology |
Bico International AB |
